As of Jul 22
| -0.17 / -1.94%|
The 8 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 8.50, with a high estimate of 16.00 and a low estimate of 4.00. The median estimate represents a -1.16% decrease from the last price of 8.60.
The current consensus among 8 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since July, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.